Literature DB >> 6445921

Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients.

G F Webster, J J Leyden, C C Tsai, P Baehni, W P McArthur.   

Abstract

Propionibacterium acnes cells were tested for the ability to trigger lysosomal hydrolase release from human polymorphonuclear leukocytes. Representative strains of P. acnes serotype I and II failed to stimulate lysosomal release in the absence of serum. P. acnes growth culture supernatants failed to trigger release under any test condition. Addition of fresh or heat-inactivated human serum resulted in lysosomal hydrolase release directly proportional to the number of P. acnes/PMN. Pooled sera from acne patients, with a high anti-P. acnes titer stimulated release to P. acnes. Preabsorption of this reagent with P. acnes cells reduced the anti-P. acnes titer and produced 93.37 +/- 11.49% inhibition of lysosomal enzyme release compared to unabsorbed anti-serum. Electron microscopy indicated that P. acnes was readily phagocytosed by PMNs when fresh or heated serum was present.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6445921     DOI: 10.1111/1523-1747.ep12544494

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

1.  Effect of Lactobacillus reuteri on the proliferation of Propionibacterium acnes and Staphylococcus epidermidis.

Authors:  Mi-Sun Kang; Jong-Suk Oh; Seok-Woo Lee; Hoi-Soon Lim; Nam-Ki Choi; Seon-Mi Kim
Journal:  J Microbiol       Date:  2012-02-27       Impact factor: 3.422

2.  Leukocyte chemotactic properties of soluble horny contents in epidermal cysts.

Authors:  H Takematsu; T Terui; W Torinuki; H Tagami
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

3.  Tretinoin: A Review of Its Anti-inflammatory Properties in the Treatment of Acne.

Authors:  Nicholas Schmidt; Eugene H Gans
Journal:  J Clin Aesthet Dermatol       Date:  2011-11

4.  Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro.

Authors:  G F Webster; J J Leyden; R A Musson; S D Douglas
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

5.  Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin.

Authors:  G F Webster; J J Leyden; K J McGinley; W P McArthur
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

6.  Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses.

Authors:  Jenny Kim; Maria-Teresa Ochoa; Stephan R Krutzik; Osamu Takeuchi; Satoshi Uematsu; Annaliza J Legaspi; Hans D Brightbill; Diana Holland; William J Cunliffe; Shizuo Akira; Peter A Sieling; Paul J Godowski; Robert L Modlin
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

Review 7.  The role of inflammation in the pathology of acne.

Authors:  Emil A Tanghetti
Journal:  J Clin Aesthet Dermatol       Date:  2013-09

8.  Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes.

Authors:  G F Webster; J J Leyden
Journal:  Inflammation       Date:  1980-09       Impact factor: 4.092

9.  Effects of subminimal inhibitory concentrations of minocycline on neutrophil chemotactic factor production in comedonal bacteria, neutrophil phagocytosis and oxygen metabolism.

Authors:  H Akamatsu; Y Niwa; I Kurokawa; R Masuda; S Nishijima; Y Asada
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

10.  p38 MAP Kinase Inhibition Reduces Propionibacterium acnes-Induced Inflammation in Vitro.

Authors:  Wen-Hwa Li; Li Zhang; Peter Lyte; Karien Rodriguez; Druie Cavender; Michael D Southall
Journal:  Dermatol Ther (Heidelb)       Date:  2015-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.